Economy

Celebrate the 2nd World ALL Day on September 20, 2023!

On September 20, 2023, Know ALL – a global education and awareness initiative that provides patients and caregivers with the information, resources, and support needed to deal with acute lymphoblastic leukemia (ALL) – will join the patient and caregiver community to mark the second World ALL Day and increase awareness of this cancer.

To show support and raise awareness of World ALL Day, Know ALL has created a downloadable resource that can be shared on websites and social channels using the hashtag #WorldALLDay. The resource allows patients, caregivers and advocates to share their experience of living with ALL, highlight the different subtype classifications and outlines key questions to ask healthcare professionals.

In addition, Know ALL encourages those involved in the initiative to share their subtype and treatment journey on social media using #WorldALLDay. Social media graphics are also available on the Know ALL website which can be translated and shared.

Know ALL is brought to you by Scientific Education Support (SES) in collaboration with the Acute Leukaemia Advocates Network (ALAN). The initiative has been made possible with the support of Amgen, Kite Pharma, BMS, and Jazz Pharmaceuticals.

A dedicated and highly experienced global ambassador group, consisting of patients, patient advocates and healthcare professionals, provides guidance to Know ALL. They suggest awareness initiatives, create support and education resources, and endorse materials before they are circulated to the ALL community.

For more information on Know ALL, its ambassadors, and how to get involved with World ALL Day, please visit: know-alleukemia.com or contact ses_knowall@scientificeducationsupport.com.

On September 20, 2023, Know ALL – a global education and awareness initiative that provides patients and caregivers with the information, resources, and support needed to deal with acute lymphoblastic leukemia (ALL) – will join the patient and caregiver community to mark the second World ALL Day.

The initiative aims to raise awareness of this cancer and encourage those involved to show their support by sharing their subtype and treatment journey on social media using #WorldALLDay. To further this, Know ALL has created a downloadable resource which is designed to provide patients, caregivers and advocates with the opportunity to share their experience of living with ALL, highlight the different subtype classifications and outline key questions to ask healthcare professionals. The resource is available to share on websites and social channels.

Know ALL is brought to you by Scientific Education Support (SES) in collaboration with the Acute Leukaemia Advocates Network (ALAN). A dedicated and highly experienced global ambassador group, consisting of patients, patient advocates and healthcare professionals, provides guidance to Know ALL. The initiative has been made possible with the support of Amgen, Kite Pharma, BMS, and Jazz Pharmaceuticals.

For more information on Know ALL, its ambassadors, and how to get involved with World ALL Day, please visit: know-alleukemia.com or contact ses_knowall@scientificeducationsupport.com.

The post Celebrate the 2nd World ALL Day on September 20, 2023! first appeared on BusinessMole.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:

TheProficientInvestor.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top